Literature DB >> 3732528

Measurements of 3 alpha,17 beta-androstanediol glucuronide in serum and urine and the correlation with skin 5 alpha-reductase activity.

R J Paulson, P C Serafini, J A Catalino, R A Lobo.   

Abstract

Serum and urinary measurements of 3 alpha,17 beta-androstanediol glucuronide (3 alpha-diol G) reflect peripheral androgen action and have been useful clinically. This study was designed to compare these levels in hirsute women, normal premenopausal and postmenopausal women, and in men and to correlate each measurement with skin 5 alpha-reductase activity (5 alpha-RA), an excellent correlate of androgenicity. Although serum 3 alpha-diol G values were similar in premenopausal and postmenopausal women, values were higher in hirsute women and in men. This pattern was similar for urinary 3 alpha-diol G but with greater overlap in values between hirsute and nonhirsute women and men. Serum 3 alpha-diol G showed a highly significant correlation with levels of genital 5 alpha-RA (r = 0.839, P less than 0.001), whereas urinary 3 alpha-diol G did not correlate. Serum and urinary 3 alpha-diol G also did not correlate with one another (r = 0.03). These data suggest that while both serum and urinary 3 alpha-diol G may be useful clinically, serum 3 alpha-diol G appears to correlate better with androgenicity and 5 alpha-RA. It is suggested further that the sources of serum and urinary 3 alpha-diol G may be somewhat different.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732528     DOI: 10.1016/s0015-0282(16)49515-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Developmental patterns of serum 3 alpha-androstanediol glucuronide.

Authors:  H L Rittner; P D Lee; W F Blum; H G Doerr; J Steiss; J Kreuder; W Rascher; W Kiess
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

2.  Developmental patterns of serum 3 alpha-androstanediol glucuronide.

Authors:  H L Rittner; P D Lee; W F Blum; H G Doerr; J Steiss; J Kreuder; W Rascher; W Kiess
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

3.  Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations.

Authors:  Michael B Cook; Frank Z Stanczyk; Shannon N Wood; Ruth M Pfeiffer; Muhannad Hafi; Carmela C Veneroso; Barlow Lynch; Roni T Falk; Cindy Ke Zhou; Shelley Niwa; Eric Emanuel; Yu-Tang Gao; George P Hemstreet; Ladan Zolfghari; Peter R Carroll; Michael J Manyak; Isabell A Sesterhann; Paul H Levine; Ann W Hsing
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-08-22       Impact factor: 4.254

4.  Altered balance between the 5 alpha-reductase and aromatase pathways of androgen metabolism during controlled ovarian hyperstimulation with human menopausal gonadotropins.

Authors:  C C Slater; L Chang; F Z Stanczyk; R J Paulson
Journal:  J Assist Reprod Genet       Date:  2001-10       Impact factor: 3.412

5.  Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism.

Authors:  R Rossi; L Tauchmanovà; A Luciano; R Valentino; S Savastano; C Battista; M Di Martino; G Lombardi
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

6.  Diagnostic value of prostatic specific antigen in hirsute women.

Authors:  S Güllü; R Emral; M Asik; M Cesur; V Tonyukuk
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.